期刊文献+

睾酮放免测定法研究醋酸亮丙瑞林口服在大鼠体内的吸收 被引量:3

The testosterone release profiles in rats by oral administration of leuprolide
下载PDF
导出
摘要 目的:建立亮丙瑞林口服给药剂量与睾酮释放间的量效关系。方法:对雄性大鼠分别灌胃给予0.005,0.05,0.5,1,5,10μg/kg,于0、1、2、4、8、12、24h取血0.5ml,血清用RIA测定睾酮含量。结果:大鼠灌胃给予亮丙瑞林游离药物1μg/kg为最大无效剂量。5μg/kg亮丙瑞林足以促进睾酮释放,再增加剂量时,睾酮浓度增加并不明显。结论:亮丙瑞林口服给药剂量与睾酮释放不成线性。 Objective: To establish the relationship between the oral administration dose of leuprolide and the release of testosterone in rats. Methods: Different doses (0.005, 0.05, 0.5, 1, 5, 10 μg/kg) were intragastrically given to male rats. Blood samples (0.5 ml) were taken at 0, 1, 2, 4, 8, 12, 24 h. The serum testosterone level was measured by RIA. Results: Oral administration of 1 μg/kg leuprolide was the maximum ineffective dose. Administration of 5 μg/kg was enough to promote testosterone release. Further increase in the dose did not promote more testosterone release. Conclusion: The oral administration dose of leuprolide is not linearly related to the testosterone release.
出处 《中国医药导报》 CAS 2008年第21期31-32,共2页 China Medical Herald
关键词 亮丙瑞林 睾酮 口服 Leuprolide Testosterone Oral administration
  • 相关文献

参考文献4

  • 1[1]Hall SC,Tan MM,Leonard JJ,et al.Characterization and comparison of leuprolide degradation profiles in water and dimethyl sulfoxide[J].J Peptide Res,1999,53:433-441.
  • 2[2]Hoffman HN,Ghanbari DJ.Stabilization of the N-terminal Residues of LHRH agonists and the effect on pharmacokinetics[J].J Med Chera,1992,35:3890-3894.
  • 3[3]Zheng Y,Fu LM,Qiu Y,et al.Enzymatic degradation of leuprolide in rat intestinal mucosal homogenates[J].Pharm Develop Technol,1999,4:539-544.
  • 4[4]Adjei P,Sundberg D,Miller J,et al.Bioavailability of leuprolide acetate following nasal and inhalation delivery to rats and healthy humans[J].Pharm Res,1992,9:244-249.

同被引文献24

引证文献3

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部